9 analysts have expressed a variety of opinions on Pfizer (NYSE:PFE) over the past quarter, offering a diverse set of opinions from bullish to bearish.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 0 | 8 | 1 | 0 | 0 |
| Last 30D | 0 | 1 | 0 | 0 | 0 |
| 1M Ago | 0 | 3 | 0 | 0 | 0 |
| 2M Ago | 0 | 1 | 1 | 0 | 0 |
| 3M Ago | 0 | 3 | 0 | 0 | 0 |
Insights from analysts' 12-month price targets are revealed, presenting an average target of $42.22, a high estimate of $45.00, and a low estimate of $29.00. This upward trend is apparent, with the current average reflecting a 3.33% increase from the previous average price target of $40.86.
Breaking Down Analyst Ratings: A Detailed Examination
A comprehensive examination...
Login or create a forever free account to read this news
Sign up/Log in